Telpegfilgrastim for chemotherapy-induced neutropenia in breast cancer: A multicenter, randomized, phase 3 study
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer
2025-02-01
|
| Series: | Chinese Medical Journal |
| Online Access: | http://journals.lww.com/10.1097/CM9.0000000000003445 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850027054794276864 |
|---|---|
| author | Yuankai Shi Qingyuan Zhang Junsheng Wang Zhong Ouyang Tienan Yi Jiazhuan Mei Xinshuai Wang Zhidong Pei Tao Sun Junheng Bai Shundong Cang Yarong Li Guohong Fu Tianjiang Ma Huaqiu Shi Jinping Liu Xiaojia Wang Hongrui Niu Yanzhen Guo Shengyu Zhou Li Sun Yanjie Yin |
| author_facet | Yuankai Shi Qingyuan Zhang Junsheng Wang Zhong Ouyang Tienan Yi Jiazhuan Mei Xinshuai Wang Zhidong Pei Tao Sun Junheng Bai Shundong Cang Yarong Li Guohong Fu Tianjiang Ma Huaqiu Shi Jinping Liu Xiaojia Wang Hongrui Niu Yanzhen Guo Shengyu Zhou Li Sun Yanjie Yin |
| author_sort | Yuankai Shi |
| collection | DOAJ |
| format | Article |
| id | doaj-art-b944e32962984a26bbdc61bc2c8dbd3c |
| institution | DOAJ |
| issn | 0366-6999 2542-5641 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Wolters Kluwer |
| record_format | Article |
| series | Chinese Medical Journal |
| spelling | doaj-art-b944e32962984a26bbdc61bc2c8dbd3c2025-08-20T03:00:21ZengWolters KluwerChinese Medical Journal0366-69992542-56412025-02-01138449649810.1097/CM9.0000000000003445202502200-00017Telpegfilgrastim for chemotherapy-induced neutropenia in breast cancer: A multicenter, randomized, phase 3 studyYuankai Shi0Qingyuan Zhang1Junsheng Wang2Zhong Ouyang3Tienan Yi4Jiazhuan Mei5Xinshuai Wang6Zhidong Pei7Tao Sun8Junheng Bai9Shundong Cang10Yarong Li11Guohong Fu12Tianjiang Ma13Huaqiu Shi14Jinping Liu15Xiaojia Wang16Hongrui Niu17Yanzhen Guo18Shengyu Zhou19Li Sun20Yanjie Yin1 Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China2 Department of Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150000, China3 Department of Oncology, Anyang Cancer Hospital, Anyang, Henan 455000, China4 Department of Oncology, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian 361000, China5 Department of Oncology, Xiangyang Central Hospital, Xiangyang, Hubei 441000, China6 Department of Oncology, Zhengzhou People’s Hospital, Zhengzhou, Henan 450000, China7 Department of Oncology, The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan 471000, China8 Department of Oncology, Luoyang Central Hospital, Luoyang, Henan 471000, China9 Department of Oncology, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital, Shenyang, Liaoning 110000, China10 Department of Breast, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi 046000, China11 Department of Oncology, Henan Provincial People’s Hospital, Zhengzhou, Henan 450000, China12 Department of Oncology & Hematology, The Second Hospital of Jilin University, Changchun, Jilin 130000, China13 Department of General Surgery, Sanya Central Hospital (Hainan Third People’s Hospital), Sanya, Hainan 572000, China14 Department of Oncology, Luohe Central Hospital, Luohe, Henan 462000, China15 Department of Oncology, The First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi 341000, China16 Department of Galactophore Surgery, Sichuan Provincial People’s Hospital, Chengdu, Sichuan 610000, China17 Department of Breast Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310000, China18 Department of Oncology, The First Affiliated Hospital of Xinxiang Medial University, Xinxiang, Henan 453000, China7 Department of Oncology, The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan 471000, China1 Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China19 Xiamen Amoytop Biotech Co., LTD, Xiamen, Fujian 361000, Chinahttp://journals.lww.com/10.1097/CM9.0000000000003445 |
| spellingShingle | Yuankai Shi Qingyuan Zhang Junsheng Wang Zhong Ouyang Tienan Yi Jiazhuan Mei Xinshuai Wang Zhidong Pei Tao Sun Junheng Bai Shundong Cang Yarong Li Guohong Fu Tianjiang Ma Huaqiu Shi Jinping Liu Xiaojia Wang Hongrui Niu Yanzhen Guo Shengyu Zhou Li Sun Yanjie Yin Telpegfilgrastim for chemotherapy-induced neutropenia in breast cancer: A multicenter, randomized, phase 3 study Chinese Medical Journal |
| title | Telpegfilgrastim for chemotherapy-induced neutropenia in breast cancer: A multicenter, randomized, phase 3 study |
| title_full | Telpegfilgrastim for chemotherapy-induced neutropenia in breast cancer: A multicenter, randomized, phase 3 study |
| title_fullStr | Telpegfilgrastim for chemotherapy-induced neutropenia in breast cancer: A multicenter, randomized, phase 3 study |
| title_full_unstemmed | Telpegfilgrastim for chemotherapy-induced neutropenia in breast cancer: A multicenter, randomized, phase 3 study |
| title_short | Telpegfilgrastim for chemotherapy-induced neutropenia in breast cancer: A multicenter, randomized, phase 3 study |
| title_sort | telpegfilgrastim for chemotherapy induced neutropenia in breast cancer a multicenter randomized phase 3 study |
| url | http://journals.lww.com/10.1097/CM9.0000000000003445 |
| work_keys_str_mv | AT yuankaishi telpegfilgrastimforchemotherapyinducedneutropeniainbreastcanceramulticenterrandomizedphase3study AT qingyuanzhang telpegfilgrastimforchemotherapyinducedneutropeniainbreastcanceramulticenterrandomizedphase3study AT junshengwang telpegfilgrastimforchemotherapyinducedneutropeniainbreastcanceramulticenterrandomizedphase3study AT zhongouyang telpegfilgrastimforchemotherapyinducedneutropeniainbreastcanceramulticenterrandomizedphase3study AT tienanyi telpegfilgrastimforchemotherapyinducedneutropeniainbreastcanceramulticenterrandomizedphase3study AT jiazhuanmei telpegfilgrastimforchemotherapyinducedneutropeniainbreastcanceramulticenterrandomizedphase3study AT xinshuaiwang telpegfilgrastimforchemotherapyinducedneutropeniainbreastcanceramulticenterrandomizedphase3study AT zhidongpei telpegfilgrastimforchemotherapyinducedneutropeniainbreastcanceramulticenterrandomizedphase3study AT taosun telpegfilgrastimforchemotherapyinducedneutropeniainbreastcanceramulticenterrandomizedphase3study AT junhengbai telpegfilgrastimforchemotherapyinducedneutropeniainbreastcanceramulticenterrandomizedphase3study AT shundongcang telpegfilgrastimforchemotherapyinducedneutropeniainbreastcanceramulticenterrandomizedphase3study AT yarongli telpegfilgrastimforchemotherapyinducedneutropeniainbreastcanceramulticenterrandomizedphase3study AT guohongfu telpegfilgrastimforchemotherapyinducedneutropeniainbreastcanceramulticenterrandomizedphase3study AT tianjiangma telpegfilgrastimforchemotherapyinducedneutropeniainbreastcanceramulticenterrandomizedphase3study AT huaqiushi telpegfilgrastimforchemotherapyinducedneutropeniainbreastcanceramulticenterrandomizedphase3study AT jinpingliu telpegfilgrastimforchemotherapyinducedneutropeniainbreastcanceramulticenterrandomizedphase3study AT xiaojiawang telpegfilgrastimforchemotherapyinducedneutropeniainbreastcanceramulticenterrandomizedphase3study AT hongruiniu telpegfilgrastimforchemotherapyinducedneutropeniainbreastcanceramulticenterrandomizedphase3study AT yanzhenguo telpegfilgrastimforchemotherapyinducedneutropeniainbreastcanceramulticenterrandomizedphase3study AT shengyuzhou telpegfilgrastimforchemotherapyinducedneutropeniainbreastcanceramulticenterrandomizedphase3study AT lisun telpegfilgrastimforchemotherapyinducedneutropeniainbreastcanceramulticenterrandomizedphase3study AT yanjieyin telpegfilgrastimforchemotherapyinducedneutropeniainbreastcanceramulticenterrandomizedphase3study |